Tirzepatide Intermediate P14 is a protected peptide fragment used in the manufacturing process of the pharmaceutical intermediate for tirzepatide. It consists of a sequence of amino acids with various tert-butyl-based protecting groups, contributing to its role in solid-phase peptide synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2461524-54-7
Tert-butyl 3-((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenyl-propanoyl)amino)-3-methyl-butanoyl)amino)-5-oxo-5-(tritylamino)pentanoyl)amino)-3-(((1S)-1-(((1S,2S)-1-(((1S)-2-(2-hydroxyethylamino)-1-methyl-2-oxo-ethyl)carbamoyl)-2-methyl-butyl)carbamoyl)-3-methyl-butyl)amino)-3-oxo-propyl)indole-1-carboxylate
protected peptide synthesis intermediate
TIRZEPATIDE INTERMEDIATE P7
Tirzepatide intermediate for peptide synthesis
L-Phenylalanine benzyl ester hydrochloride
Peptide synthesis intermediate
L-Valine benzyl ester hydrochloride
Pharmaceutical intermediate
Somatorelin
diagnostic agent for growth hormone deficiency
Sermorelina
growth hormone releasing factor analog
L-tyrosyl-D-alanyl-L-alpha-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-alpha-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-argininamide
active pharmaceutical ingredient
Tesamorelin
growth hormone releasing factor analog
(2S)-4-methyl-2-[[2-methyl-2-[[(2S,3S)-3-methyl-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-[4-[(2-methylpropan-2-yl)oxy]phenyl]propanoyl]amino]propanoyl]amino]-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoyl]amino]acetyl]amino]-3-[(2-methylpropan-2-yl)oxy]butanoyl]amino]-3-phenylpropanoyl]amino]-3-[(2-methylpropan-2-yl)oxy]butanoyl]amino]-3-[(2-methylpropan-2-yl)oxy]propanoyl]amino]-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoyl]amino]-3-[4-[(2-methylpropan-2-yl)oxy]phenyl]propanoyl]amino]-3-[(2-methylpropan-2-yl)oxy]propanoyl]amino]pentanoyl]amino]propanoyl]amino]pentanoic acid
VWFRKLBJNTUPQZ-ZPHZDWMKSA-N
CC[C@H](C)[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)OC(C)(C)C)NC(=O)[C@H](CC(=O)OC(C)(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H]([C@@H](C)OC(C)(C)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H]([C@@H](C)OC(C)(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)C(C)(C)NC(=O)[C@H](CC3=CC=C(C=C3)OC(C)(C)C)NC(=O)OC(C)(C)C